IMMUNOLOGIX, INC.

Profile

Company Names

IMMUNOLOGIX, INC.

Addresses

645 MEETING STREET, SUITE 8, CHARLESTON, SC 29403

645 MEETING STREET, CHARLESTON, SC 29403

Phone Numbers

843-789-5904

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$1,341,116.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2011-07-15 
$250,948.00 
$1,125,000.00 
$874,052.00 
Equity 
1
2010-03-18 
$1,090,168.00 
$1,250,000.00 
$159,832.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
BARTOSH 
DIRECTOR
IMMUNOLOGIX, INC.   |  MORRIS INNOVATIVE INC.
DOUGLAS 
M. 
CARNES 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOLOGIX, INC.   |  KERDEA TECHNOLOGIES, INC.   |  BLINKTBI, INC.
RYAN 
N. 
FIORINI 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOLOGIX, INC.   |  PERLE BIOSCIENCE, INC.   |  BLINKTBI, INC.
ROBERT 
 
KENNEDY 
DIRECTOR
IMMUNOLOGIX, INC.   |  515 VENTURES, LLC   |  VESTARON CORP   |  KENNEDY SHOES, LLC   |  DERBY EXPLORATION, LLC   |  OSTARA NUTRIENT RECOVERY TECHNOLOGIES INC   |  UNCOMMON GIVING CORP   |  ENCINA LENDER FINANCE, LLC   |  ENCINA LENDER FINANCE INTERMEDIATE SPV, LLC   |  ON TRACK TECHNOLOGIES INC   |  ENCINA PRIVATE CREDIT INTERMEDIATE HOLDCO, LLC   |  ENCINA PRIVATE CREDIT HOLDCO, LLC   |  GRABTV, INC.   |  SNIFFER ROBOTICS, INC.   |  UG, LLC
RICHARD 
A. 
MCGREGOR 
DIRECTOR
IMMUNOLOGIX, INC.
LLOYD 
A. 
PEARSON 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOLOGIX, INC.   |  KERDEA TECHNOLOGIES, INC.   |  PERLE BIOSCIENCE, INC.
SAM 
 
TETLOW 
DIRECTOR
IMMUNOLOGIX, INC.   |  BIOFLUIDICA, INC.   |  AMALGENT THERAPEUTICS, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-07-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-15 
2010-08-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-18 
2010-04-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#